Sélection de publications

• 926eP - Functional chemosensitivity testing using primary and metastatic tumour samples in metastatic colorectal cancer

  Mathonnet M, Lautrette C, Giraud S, Christou N, Ouaissi M, Sabbagh C, Regimbeau JM, Labrunie A, Magne J, Girard M.

  ESMO Congress 2026. ePoster 926eP.

• The Oncogramme® Predicts the Response of Metastatic Ovarian Cancer to Chemotherapeutic Treatment: Link with Patient Care Pathway through Peritoneal Cancer Index, RECIST Criteria 1.1 and Resective Surgical Operability: A Pilot Study

  Stéphanie GIRAUD, Tristan GAUTHIER, Ophélie PASINI-CHABOT, Renaud MARTIN, Véronique FERMEAUX, Sandrine LUCE, Pierre-Marie PREUX, Elise DELUCHE, Nicole TUBIANA-MATHIEU, Laurence VENAT, Anne FLOQUET, Frédéric GUYON, Joëlle MOLLARD, Aurélie PERRAUD and Christophe LAUTRETTE

  J Cancer Res Therap Oncol. 2026; vol 14: 102.

• Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept

  Christophe Bounaix Morand du Puch, Mathieu Vanderstraete, Stéphanie Giraud, Christophe Lautrette, Niki Christou, Muriel Mathonnet

  Theranostics. 2021 Sep 21;11(19):9538-9556.

• ONCOGRAM: study protocol for the evaluation of therapeutic response and survival of metastatic colorectal cancer patients treated according to the guidelines of a chemosensitivity assay, the Oncogramme®

  Muriel Mathonnet, Mathieu Vanderstraete, Christophe Bounaix Morand du Puch, Stéphanie Giraud, Christophe Lautrette, Mehdi Ouaissi, Nicolas Tabchouri, Abdelkader Taïbi, Renaud Martin, Isabelle Herafa, Achille Tchalla, Niki Christou & The ONCOGRAM trial investigators

  Trials. 2021 Aug 21;22(1):556.

• Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancer

  Christophe Bounaix Morand du Puch, Michelle Nouaille, Stéphanie Giraud, Anaïs Labrunie, Sandrine Luce, Pierre-Marie Preux, François Labrousse, Alain Gainant 8, Nicole Tubiana-Mathieu, Valérie Le Brun-Ly , Denis Valleix, Angélique Guillaudeau, Laura Mesturoux, Béma Coulibaly, Christophe Lautrette, Muriel Mathonnet

  J Transl Med. 2016 Jan 12;14:10.

• Sedimentation field flow fractionation monitoring of in vitro enrichment in cancer stem cells by specific serum-free culture medium

  Mélin C, Perraud A, Bounaix Morand du Puch C, Loum E, Giraud S, Cardot P, Jauberteau MO, Lautrette C, Battu S, Mathonnet M.

  J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jul 15;963:40-6.

• Discrimination of colorectal cancer cell lines using microwave biosensors

  Zhang LY, Bounaix Morand du Puch C, Dalmay C, Lacroix A, Landoulsi A, Leroy J, Mélin C, Lalloué F, Battu S, Lautrette C, Giraud S, Bessaudou A, Blondy P, Jauberteau MO, Pothier A.

  Sensors and Actuators A 216 (2014) 405–416.

• Oncogramme, an Adapted Method for Individualized Tumour Response Testing of Ovary Cancer Treatments

  Giraud S, Croce S, Bessette B, Stoeckle E, Guyon F, Mac Grogan G, Floquet A, Velasco V, Mannina C, Lautrette C.

  J Cancer Res Therap Oncol. 2014; 2: 1-9

• Oncogramme responses of breast tumour cells treated with herceptin correlate with HER2/C-ERB B2 pathological status

  Giraud S, Bounaix Morand du Puch C, Fermeaux V, Guillaudeau A, Lautrette C.

  Anticancer Res. 2012 Apr;32(4):1323-5.

• Oncogramme, a new promising method for individualized breast tumour response testing for cancer treatment

  Giraud S, Loum E, Bessette B, Fermeaux V, Lautrette C.

  Anticancer Res. 2011 Jan;31(1):139-45.

• Oncogramme, a new individualized tumor response testing method: application to colon cancer

  Loum E, Giraud S, Bessette B, Battu S, Mathonnet M, Lautrette C.

  Cytotechnology. 2010 Oct;62(5):381-8.